BridgeMD
New treatment option for Frailty
Official title South Korean Study to Prevent Frailty and Aging-related Diseases Through Lifestyle Intervention
ClinicalTrials.gov ID: NCT06891573
What this study is testing
- What it's testing
- The goal of this feasibility randomized controlled trial is to investigate the applicability of software that aims to improve symptoms of frailty by implementing customized interventions such as physical exercise and cognitive training implemented through a mobile app for 16 weeks for patients diagnosed with frailty or prefrailty. The primary outcomes are adherence, retention rates, and recruitment rates.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 90
You may be able to join if
- 60-90 years of age
- Residing in the community
- Total score of Modified Fried frailty phenotype score ≥ 1 point
- Korean Mini-Mental State Examination-2 z-score ≥ -1.5
- Can read and write
You likely can't join if
- Major psychiatric illness such as major depressive disorders
- Dementia
- Other neurodegenerative disease (e.g., Parkinson's disease)
- Malignancy within five years
- Cardiac stent or revascularization within one year
- Serious or unstable symptomatic cardiovascular disease
See the full eligibility criteria
- 60-90 years of age
- Residing in the community
- Total score of Modified Fried frailty phenotype score ≥ 1 point
- Korean Mini-Mental State Examination-2 z-score ≥ -1.5
- Can read and write
- Being able to use the a mobile app through education or having someone help a participant use the mobile app
- Having a reliable informant who could provide investigators with the requested information.
- written informed consent
- Major psychiatric illness such as major depressive disorders
- Dementia
- Other neurodegenerative disease (e.g., Parkinson's disease)
- Malignancy within five years
- Cardiac stent or revascularization within one year
- Serious or unstable symptomatic cardiovascular disease
- Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease
- Severe loss of vision, hearing, or communicative disability
- Significant laboratory abnormality that may result in cognitive impairment
- Any conditions preventing cooperation as judged by the study physician
- Unable to participate in exercise program safely
- Coincident participation in any other intervention trial
The study team makes the final eligibility decision.
Where it's taking place
- Incheon, South Korea
- Seoul, South Korea
- Suwon, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Incheon, South Korea; Seoul, South Korea; Suwon, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.